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An inﬂ  uenza A virus (H3N2) of probable swine origin, 
designated A/Canada/1158/2006, was isolated from a 7-
month-old hospitalized child who lived on a communal farm 
in Canada. The child recovered uneventfully. A serosurvey 
that used a hemagglutination-inhibition assay for A/Can-
ada/1158/2006 was conducted on 54 of the 90 members 
of the farm. Seropositivity was demonstrated in the index 
patient, 4 of 7 household members, and 4 of 46 nonhouse-
hold members; none had a history of hospital admission for 
respiratory illness in the preceding year. Serologic evidence 
for this strain of swine inﬂ  uenza was also found in 1 of 10 
pigs (12 weeks–6 months of age) on the farm. Human infec-
tion with swine inﬂ  uenza virus is underrecognized in Cana-
da, and because viral strains could adapt or reassort into a 
form that results in efﬁ  cient human-to-human transmission, 
routine surveillance of swine workers should be considered 
as part of pandemic inﬂ  uenza preparedness.
I
nﬂ  uenza A is endemic in a broad range of species, with 
avian and swine strains having the greatest potential for 
transmission to humans. Pandemics of inﬂ  uenza A occur 
when a major change occurs in the proteins of circulating 
strains of the virus. During the pandemics of the past centu-
ry, this antigenic shift resulted from reassortment of human 
and avian strains or adaptation of avian viruses to facilitate 
person-to-person transmission (1). Avian inﬂ  uenza prefer-
entially binds to sialic acid–galactose receptors with an
α-2,3 linkage that is abundant on duck intestinal epitheli-
um; human inﬂ  uenza preferentially binds to sialic acid–ga-
lactose receptors with an α-2,6 linkage that is abundant on 
human respiratory epithelium. The respiratory epithelium 
of swine contains both types of receptors and can poten-
tially be simultaneously infected with avian and human in-
ﬂ  uenza (2). Human infection with avian inﬂ  uenza subtype 
H5N1 is of great concern, with 194 deaths of 321 cases 
reported worldwide through August 16, 2007 (3). Swine 
infected with avian subtype H5N1 have been identiﬁ  ed in 
Vietnam (4), raising the possibility that swine could act as 
the “mixing vessel” that allows avian inﬂ  uenza (H5N1) to 
reassort with a human inﬂ  uenza strain, resulting in a virus 
with high pathogenicity and a high potential for person-to-
person spread.
Another theoretical mechanism for the origin of an in-
ﬂ  uenza pandemic would be the adaptation of a swine strain 
that results in efﬁ  cient person-to-person transmission, al-
though cross-protection by antibodies to recently circulat-
ing human strains may prevent this from occurring with 
swine inﬂ  uenza virus (SIV) H1 and H3 strains. Infection 
of humans with SIV was ﬁ  rst recognized in 1974 with an 
H1N1 strain (5); the solitary outbreak occurred in military 
recruits at Fort Dix, New Jersey, USA, in 1976 (6). Hu-
man infection with SIV subtype H3N2 was ﬁ  rst described 
in Europe in 1993 (7). The ﬁ  rst reported case of probable 
infection of a person in North America with a non-H1N1 
subtype of SIV occurred in Ontario, Canada, in 2005 with 
an H3N2 strain detected in the respiratory tract of an adult 
with no serologic evidence of infection (8). We describe a 
case of SIV (H3N2) infection in a Canadian infant, con-
ﬁ  rmed by viral isolation and serologic testing.
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Case Report
A 7-month-old boy was admitted to the hospital on Sep-
tember 10, 2006, with a 3-day history of fever, rhinitis, and 
cough. He had had no previous contact with ill persons. The 
child was born at term and was hospitalized for 21 days at 
5 weeks of age when he received ventilation for 6 days for 
pneumonia due to respiratory syncytial virus. He lived on 
a communal farm (90 occupants) with horses, cows, swine, 
sheep, dogs, cats, turkeys, geese, ducks, and chickens but 
had no direct contact with the animals. The swine were con-
tained in barns and did not mix with the other animals. His 
household contacts did not work directly with animals, but 
his father occasionally spent time in the barns, and his uncle, 
who lived next door, worked in the swine barns.
On admission, the child was afebrile with a heart rate of 
120 beats/min, respiratory rate 56/min, and oxygen satura-
tion of 85% on room air. Diffuse wheeze was noted. Chest 
radiograph results were unremarkable. Direct ﬂ  uorescent 
antibody testing on a nasopharyngeal aspirate was positive 
for inﬂ  uenza A, and the virus was isolated in rhesus monkey 
cell culture. The isolate was sent to the National Microbiol-
ogy Laboratory for inﬂ  uenza subtyping as a requirement of 
the Canadian inﬂ  uenza surveillance program, where it was 
subsequently designated A/Canada/1158/2006. The child 
stayed in the hospital for 2 days and then made an unevent-
ful recovery at home. A cough and rhinitis developed in 
his 19-month-old brother on the day the index patient was 
admitted to the hospital, but the brother was not assessed 
by a physician. 
Methods
Antigenic Analysis
For the antigenic characterization of A/Canada/
1158/2006, hemagglutination-inhibition (HI) assay was 
performed by using 4 hemagglutination units of virus, 
0.7% v/v guinea pig erythrocytes, and postinfection fowl 
serum specimens for the currently circulating human 
strains (A/New Caledonia/20/99 [H1N1], A/Wisconsin/
67/2005 [H3N2]), past circulating human strains (A/Panama/
2007/99 and A/Nanchang/933/95), and swine serum for 
A/Swine/Texas/4199–2/98 (H3N2) treated with receptor-
destroying enzyme (9).
Molecular Characterization
All 8 RNA segments of A/Canada/1158/2006 were 
ampliﬁ   ed by reverse transcriptase–PCR (RT-PCR) and 
sequenced. A universal primer set for the full-length am-
pliﬁ   cation of all inﬂ   uenza A viruses was used for the 
RT-PCR (10). Viral RNA was extracted from 100 μL of 
tissue culture ﬂ  uid with the RNeasy Mini Kit (QIAGEN, 
Mississauga, Ontario, Canada). Viral RNA was ampliﬁ  ed 
in a OneStep RT-PCR reaction (QIAGEN) following the 
manufacturer’s recommendations. Brieﬂ  y, 5 μL RNA was 
added to the RT-PCR mixture containing 2 μL QIAGEN 
OneStep RT-PCR enzyme mix, 10 μL 5× QIAGEN On-
eStep RT-PCR buffer, 400 μmol/L dNTP, 0.6 μmol/L of 
each primer, and 10 μL Q-solution in a ﬁ  nal volume of 
50 μL. The conditions used for the Gene Amp 97700 (Ap-
plied Biosystems, Streetsville, Ontario, Canada) thermo-
cycler were as follows: 50°C for 30 min for reverse tran-
scription, 95°C for 15 min for the activation of the HotStart 
DNA polymerase; then 35 cycles of 94°C for 20 s, 58°C for 
30 s, 72°C for 4 min, followed by an extension of 10 min at 
72°C. The PCR products were puriﬁ  ed by using QIAquick 
PCR puriﬁ  cation kit (QIAGEN) and sequenced on an ABI 
377 Sequencer, using a ﬂ  uorescent dye-terminator kit (Ap-
plied Biosystems). The DNA sequences were assembled 
and analyzed with SEQMAN, EDITSEQ, and MEGALIGN 
programs in Lasergene (DNASTAR, Madison, WI, USA). 
Phylogenetic trees were generated by the neighbor-joining 
method using the MEGA program (11).
Serologic Testing
Once it became evident that A/Canada/1158/2006 
was closely related to swine inﬂ  uenza viruses, HI was per-
formed on serum specimens collected from the index pa-
tient, the symptomatic sibling, and both parents 29 days 
after the hospitalization. To further investigate the spread 
of SIV to humans, approval was then granted by the Health 
Research Ethics Board of the University of Alberta to ob-
tain information and serum specimens from other members 
of the communal farm. The study team visited the farm 3 
months after the hospitalization of the index patient and ex-
plained the study to the occupants. Serum specimens were 
then collected from the other 4 siblings of the index patient 
and 46 other occupants who lived in a total of 17 house-
holds. Participants provided the following data: age, expo-
sure to swine (none, <1 hour/week, or >1 hour/week), and 
history of inﬂ  uenza-like illnesses (ILI; deﬁ  ned as cough 
and fever) in the preceding year. Serum samples were 
tested by using an HI assay against the currently circulat-
ing human strains A/New Caledonia/20/99 (H1N1), A/
Wisconsin/67/2005 (H3N2), and the isolate from the index 
patient, A/Canada/1158/2006. HI titers were deﬁ  ned as the 
reciprocal of the highest dilution of serum that completely 
inhibited hemagglutination of a 0.7% solution of guinea pig 
erythrocytes. Specimens were considered seropositive for 
inﬂ  uenza virus at a titer of >32.
Swine Investigation
The purpose of these investigations was to determine 
the extent of recent swine inﬂ  uenza in swine on the farm 
and to look for evidence of infection with the SIV strain 
isolated from the index child. The history of inﬂ  uenza or 
unexpected respiratory illness in the swine on the farm was 
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obtained. Nasal swabs were obtained from grower pigs (4 
to 16 weeks of age) and processed by RT-PCR for inﬂ  u-
enza A matrix gene. Serologic testing for inﬂ  uenza, using 
an ELISA for H1N1 and H3N2 strains and HI for A/Can-
ada/1158/06, was performed on samples from grower-ﬁ  n-
isher pigs (12 weeks to 6 months of age). Five grower pigs 
that were doing poorly were killed and pulmonary autop-
sies were performed. All swine used in these investigations 
were on the farm at the time the index child was ill.
Results
Antigenic and Molecular Characterization 
of A/Canada/1158/06
Initial HI testing showed that the isolate was not inhib-
ited by antiserum against recent (A/Wisconsin/77/2005 and 
A/New Caledonia/20/99) and past (A/Panama/2007/99 and 
A/Nanchang/933/95) human inﬂ  uenza A strains but was 
inhibited by antiserum against A/swine/Texas/4199–2/98 
(H3N2) virus with HI titer of 128. These ﬁ  ndings indicate 
that the A/Canada/1158/06 virus was antigenically related 
to SIV (Table 1). The results also indicate that the assay is 
speciﬁ  c because no cross-reactivity was observed between 
the human reference strain antiserum and the swine inﬂ  u-
enza viruses (Table 1). Nucleotide sequences of the full-
length coding regions of all 8 RNA segments of the isolate 
further determined that it was most closely related to A/
swine/Ontario/33853/2005 (H3N2) virus, which shares the 
same human/classic swine/avian triple reassortant geno-
type as the H3N2 subtype viruses that emerged in swine 
in the United States in 1998 (8). Sequence analysis showed 
that nucleic acid homology between A/Canada/1158/2006 
and A/swine/Ontario/33853/2005 ranges from 98.4% (HA) 
to 100% (M1), and that amino acid (aa) identities range 
from 97.9% (HA) to 100% (NP, NS2, M1). A deletion of 4 
aa at position 156–159 was observed in the HA1 region of 
the A/Canada/1158/2006 HA protein. Amino acid substitu-
tions were found in the HA (HA1 domain: G7, K142, S162; 
HA2 domain: T77, Q139, M149, E150, N160), neurami-
nadase (NA) protein (P45, K74, N150, M349, L354), NS1 
(M112), PB1 (K211, D738), PB2 (K368, S661, T722), and 
PA (V44, R99, I42) proteins. Phylogenetic analysis showed 
that all of the genes of A/Canada/1158/06 clustered with 
Canadian swine isolates from 2005 (9) (data not shown). 
Nucleic acid identity between the HA and NA genes of A/
Canada/1158/06 and the current vaccine strain A/Wiscon-
sin/67/05 was 90.9% and 94.6%, and the aa identities were 
90.2% and 94.5%, respectively.
Serologic Testing
Seropositivity (HI titer >32) to A/Canada/1158/2006 
was demonstrated in the index patient, the symptomatic 
sibling, 1 asymptomatic sibling, and both parents (Table 2, 
household A). Three other siblings were seronegative. Four 
children from 2 other households were also seropositive 
(Table 2, households B and C); the father from household 
B, 1 other child from household B, and the mother from 
household C were seronegative. The father from household 
C worked in the swine barn but was unavailable for testing. 
History of ILI within the preceding 12 months in seroposi-
tive participants was reported only for the index patient and 
for a 3-year-old girl from household C who was not hospi-
talized or tested for inﬂ  uenza virus during her illness. Sero-
negative results were obtained from another 20 adults (14 
women and 6 men) and 19 children (8 girls and 11 boys) 
from 14 different households. For these households, swine 
exposure was reported as none for 9 adults and 7 children, 
<1 hour/week for 11 adults and 8 children, and >1 hour/
week for 4 children including 3 teenagers who worked in 
the swine barns. When serum samples from the 54 partici-
pants in the study were tested for HA-speciﬁ  c antibodies to 
the current human inﬂ  uenza A virus H3N2 and H1N1 sub-
types, one of the patients who was seropositive for SIV at 
a titer of 32 had an identical titer for A/Wisconsin/67/2005 
(H3N2) (Table 2), and one of the adults who was seronega-
tive for SIV had a titer of 32 for A/New Caledonia/20/99 
(H1N1) (data not shown). All other persons tested were se-
ronegative for the 2 human strains of inﬂ  uenza.
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Table 1. Hemagglutination-inhibition reaction of A/Canada/1158/2006 isolates with reference antiserum against currently circulating
human and swine viruses 
Antiserum (titers) 
Antigen
A/New Caledonia/
20/99
(human H1N1) 
A/Wisconsin/
67/2005
(human H3N2) 
A/Panama/
2007/99
(human H3N2) 
A/Nanchang/
933/95
(human H3N2)  
A/Swine/Texas/
4199–2/98
(swine H3N2) 
Control
 A/New  Caledonia/20/99   
 (human  H1N1) 
320 <4 <4 <4 <4
 A/Wisconsin/67/2005   
 (human  H3N2) 
<4 320 64 8 8
 A/Ontario/RV1273/2005   
 (swine  H3N2) 
<4 <4 <4 <4 256
Patient
A/Canada/1158/2006 <4 <4 <4 <4 128RESEARCH
Swine Investigation
Inﬂ  uenza (H3N2) was last documented in the swine 
herd in September 2005. The herd received breeding ani-
mals from a Manitoba herd, where swine inﬂ  uenza of an 
unknown subtype had recently been documented. Nasal 
swabs collected from 25 grower pigs ≈3 weeks after the in-
dex child was ill were negative for SIV. Serum specimens 
obtained from 10 grower-ﬁ  nisher pigs were all negative by 
ELISA for swine inﬂ  uenza (H1N1), but 4 were positive for 
swine inﬂ  uenza (H3N2) strains, with 1 of these 4 strains 
being seropositive for A/Canada/1158/2006 by HI assay 
(HI titer 32). Results of the lung autopsies all showed evi-
dence of subacute bronchointerstitial pneumonia, varying 
from mild to moderate. Lesions typical for swine inﬂ  uenza 
were not noted, but an initial insult due to SIV could not 
be excluded.
Discussion
We describe an infant with virologic and serologic 
evidence of infection with SIV (H3N2) and an ILI. Sero-
logic evidence of infection with the same strain was found 
in 4 of 7 household members and in 3 of 46 nonhousehold 
contacts, with only 1 of the seropositive patients having a 
history of an ILI within the preceding year, which dem-
onstrated unrecognized human infection with SIV. This 
relatively high seroprevalence is in contrast to a recent 
outbreak of avian inﬂ  uenza (H7N3) in which seropositiv-
ity was not documented in 91 persons exposed to infected 
poultry, including 2 poultry workers from whom the virus 
was isolated (12). The difference in the apparent incidence 
of infection may be explained in part by the fact that culling 
of infected poultry occurred immediately; in our study, in-
fection of swine was not recognized and long-term human 
exposure may have occurred.
Infection of swine with human inﬂ  uenza viruses has 
been recognized for decades (2); in a recent US study, 
22.8% of pigs were seropositive for human inﬂ  uenza vi-
ruses, although some may have had vaccine-induced im-
munity (13). Swine inﬂ  uenza (H3N2) emerged in 1998 in 
the United States, where subtype H1N1 viruses had pre-
dominated for 60 years (2). The isolate from this current 
study is closely related to triple reassorting genotype vi-
ruses that spread rapidly throughout the US swine popula-
tion and have HA, NA, and RNA polymerase (PB1) genes 
of human inﬂ  uenza virus lineage; nucleoprotein, matrix, 
and nonstructural genes of classic swine inﬂ  uenza (H1N1) 
lineage; and RNA polymerase (PA and PB2) genes of 
North American avian virus lineage (8). However, triple 
reassortant SIV was not documented in swine in Canada 
until 2005 (8), which makes it unlikely that human cases 
occurred before that year and that seroreversion had oc-
curred in any of the persons in the current serosurvey.
A previous study showed cross-reactivity in HI assay 
between the vaccine strain A/Panama/2007/99 reference an-
tiserum and the triple reassortant A/swine/Minnesota/593/99, 
which is not unexpected since the HA gene of the triple re-
assortant viruses is a descendant of human viruses that cir-
culated in 1995 (14,15). However, no cross-reactivity was 
observed between the reference human strain antiserum and 
the isolate from this study, which suggests that the serocon-
version observed was indeed due to infection with swine in-
ﬂ  uenza (H3N2) and not to cross-reactive antibody to human 
inﬂ  uenza (H3N2) infection. The low rate of seropositivity to 
recently circulating strains of human inﬂ  uenza in the study 
is likely explained by the fact that the farm is a relatively 
closed community. The child who was seropositive for both 
human and swine inﬂ  uenza viruses was likely exposed to 
both viruses. The HA protein of A/Canada/1158/2006 di-
verges signiﬁ  cantly from the one of A/Wisconsin/67/2005, 
and antiserum against A/Wisconsin/67/2005 does not inhibit 
A/Canada/1158/2006 in HI assay.
Swine inﬂ  uenza (H3N2) has recently reassorted with 
H1N1 strains to produce H1N2 subtypes and has spread to 
turkeys in the United States (16) and Canada (8). A 4-aa de-
letion was found in the HA protein of A/Canada/1158/2006 
when compared with similar swine inﬂ  uenza  (H3N2) 
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Table 2. Clinical features and hemagglutination-inhibition reaction of positive antiserum from 9 members of 3 different households of a 
communal farm with recently circulating swine influenza (H3N2) virus A/Canada/1158/2006* 
Household Age, y  Sex
A/Wisconsin/
67/2005 titer 
A/New Caledonia/ 
20/99 titer 
A/Canada/
1158/2006 titer Swine exposure  Clinical features 
A (index 
patient)
0.6 M <4 <4 256 None Hospitalization with ILI and 
isolation of swine influenza 
A† 1 M <4 <4 256 None None (URI coincident with ILI 
in index case) 
A 35 F <4 <4 32 None None
A 38 M 8 <4 32 <1 h/wk None
A 8 M <4 <4 64 <1 h/week None
B 7 M 32 <4 32 <1 h/wk None
C8 M 4 < 4 6 4 >1 h/week  None
C 5 M <4 <4 128 <1 h/week 
C 3 F <4 <4 128 None ILI 1 mo before index case 
*URI, upper respiratory illness; ILI, influenza-like illness. 
†Symptomatic sibling. Swine Inﬂ  uenza (H3N2), Canada
strains currently circulating in North America. This region 
of the protein has been assigned to antigenic sites (17) 
and has been associated with adaptation to growth in eggs 
(18). Phylogenetic analysis showed that each of the 8 viral 
genes of A/Canada/1158/2006 clustered with A/swine/On-
tario/33853/2005 (H3N2) and other swine/turkey Canadian 
isolates from 2005. Although the HA gene of these isolates 
were shown to be closely related to American viruses that 
were ﬁ  rst isolated from pigs in 1999, they represent a new 
distinct cluster (2). The NA genes are phylogenetically dis-
tinct from the US swine isolates and are represented by hu-
man inﬂ  uenza (H3N2) isolates from Asuncion, Paraguay 
(2001), and New York (2003) (2).
A recent review described 50 cases of symptomatic 
human infection with SIV, documented in the literature 
through April 2006; 46 cases were infected with subtype 
H1N1 and 4 were infected with subtype H3N2 (19). The 
spectrum of pathogenicity of SIV infection ranges from as-
ymptomatic infection (6) to death; 7 of these 50 patients 
died (5,20–24). Laboratory-conﬁ  rmed swine inﬂ  uenza in 
humans may be “the tip of the iceberg.” Diagnosis of the 
current case was serendipitous because typing was per-
formed only because the case occurred outside of inﬂ  uenza 
season.
The mode of spread of SIV in humans is not estab-
lished. Because of his young age, the index patient was not 
likely to have had unrecognized direct contact with swine. 
That aerosolization of inﬂ  uenza virus occurs is increasingly 
recognized (25), but the child was reportedly never in the 
barns that housed the swine. However, other members of 
the farm reported that infants were sometimes taken for 
walks through the barn. The child also may have acquired 
the virus from person-to-person spread or from fomites. All 
13 patients in the Fort Dix outbreak and 15 of 37 previously 
reported civilian case-patients also had no swine contact 
(19,20).
The Fort Dix outbreak of SIV in humans lasted only 
21 days and never spread outside the military base. The 
calculated basic reproductive rate (R0) was only 1.1 to 1.2. 
This suggests that person-to-person spread of the implicat-
ed H1N1 strain was not efﬁ  cient enough to produce a major 
epidemic (26). However, future strains of SIV could have a 
higher R0, and documentation of a case of swine inﬂ  uenza 
(H3N2) in a child with unrecognized transmission within 
the community adds another possible mechanism by which 
major epidemics of inﬂ  uenza could arise. Swine inﬂ  uenza 
infection in humans most commonly results in either no 
symptoms or a self-limited illness (6). However, routine 
surveillance for cases among swine workers may enable 
early detection of a strain with the potential for person-
to-person transmission, prompting institution of infection 
control measures and vaccine development.
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